Product/Composition:- | L-asparaginase |
---|---|
Strength:- | 10,000 IU/vial (IV or IM injection); 2,500 IU/vial (IV infusion) |
Form:- | IV Infusion and IV/ IM Injection |
Reference Brands:- | Elspar® , Asparlas®, Erwinase® (US & EU) |
MOQ | As per the manufacturer batch size |
Get Quote Send Enquiry on WhatsApp |
L-asparaginase is used to treat acute lymphoblastic leukemia (ALL) and lymphomas by depleting the amino acid asparagine. Available under brands like Elspar®, Asparlas®, and Erwinase®, it comes in strengths such as 10,000 IU/vial and 2,500 IU/vial. Administered via IV or IM injection, it is widely sourced by B2B pharmaceutical wholesalers in the US and EU, ensuring reliable, GMP-compliant supply and competitive pricing for oncology centers.
L-asparaginase is an essential enzyme-based chemotherapy used in the treatment of acute lymphoblastic leukemia (ALL) and lymphomas. It works by depleting asparagine, an amino acid needed for cancer cell survival. Available under brands like Elspar®, Asparlas®, and Erwinase®, it is offered in strengths such as 10,000 IU/vial and 2,500 IU/vial. Administered via intravenous (IV) or intramuscular (IM) injection, L-asparaginase is widely sourced by B2B pharmaceutical wholesalers in the US and EU. These therapies ensure reliable GMP-compliant distribution for oncology centers, offering competitive pricing and consistent supply for cancer treatment.
Embrace a platform that empowers you to invest in gold online effortlessly, making the path to financial growth accessible to everyone.
Get access to the finest pharmacy products with a NazarethPharmacy.com. They offer comprehensive worldwide pharmacy services, making them your best choice for online medications